References
- Røseth AG, Kristinsson J, Fagerhol MK, Schjonsby H, Aadland E, Nygaard K, et al. Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol 1993; 28:1073–6.
- Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990;336 (8718): 763–5.
- Fagerhol MK, Dale I, Anderson I. Release and quantitation of leukocyte derived protein (L1). Scand J Haematol 1980;24: 393–8.
- Bjerke K, Halstensen TS, Jahnsen F, Pulford K, Brandtzaeg P. Distribution of macrophages and granulocytes expressing L1 protein (calprotectin) in human Peyer’s patches compared with normal ileal lamina propria and mesenteric lymph nodes. Gut 1993;34: 1357–63.
- Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF, et al. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 1997;50:113–23.
- Dale I. Plasma levels of the calcium-binding L1 leukocyte protein: standardization of blood collection and evaluation of reference intervals in healthy controls. Scand J Clin Lab Invest 1990;50:837–41.
- Holt J, Fagerhol MK, Dale I. Quantitation of a leukocyte protein (L1) in urine. Acta Paediatr Scand 1983;72: 615–6.
- Loftus B, Loh LC, Curran B, Henry K, Leader M. Mac387: its non-specificity as a tumour marker or marker of histiocytes [see comments]. Histopathology 1991;19: 251–5.
- Dale I, Brandtzaeg P. Expression of the epithelial L1 antigen as an immunohistochemical marker of squamous cell carcinoma of the lung. Histopathology 1989;14:493–502.
- Tungekar MF, Heryet A, Gatter KC. The L1 antigen and squamous metaplasia in the bladder. Histopathology 1991;19: 245–50.
- Kristinsson J, Roseth A, Fagerhol MK, Aadland E, Schjonsby H, Bormer OP, et al. Fecal calprotectin concentration in patients with colorectal carcinoma. Dis Colon Rectum 1998;41:316–21.
- Ahlquist DA, Schwartz S, Isaacson J, Ellefson M. A stool collection device: the first step in occult blood testing. Ann Intern Med 1988;108:609–12.
- Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932;35:323–32.
- Morson BC. Precancerous and early malignant lesions of the large intestine. Br J Surg 1968;55:725–31.
- Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine [published erratum appears in Clin Chem 1993;39:1589]. Clin Chem 1993;39:561–77.
- Yui S, Yang D, Mikami M, Yamazaki M. Characterization of cell growth-inhibitory factor in inflammatory peritoneal exudate cells of rats. Microbiol Immunol 1993;37:961–9.
- Murao SC, Huberman FE. A protein complex expressed during terminal differentiation of monomyelocytic cells is an inhibitor of cell growth. Cell Growth Differ 1990;1:447–54.
- Kijlstra A, Broersma L. Lactoferrin stimulates the production of leucocyte migration inhibitory factor by human peripheral mononuclear leucocytes. Clin Exp Immunol 1984;55:459–64.
- Kristinsson J, Røseth AG, Sundset A, Nygaard K, Loberg EM, Paulsen JE, et al. Granulocyte marker protein is increased in stools from rats with azoxymethane-induced colon cancer. Scand J Gastroenterol 1999;34:1216–23.
- Thomas WM, Pye G, Hardcastle JD. Faecal occult blood screening for colorectal neoplasia: a randomized trial of three days or six days of test. Br J Surg 1990;77:277–9.
- Ahlquist DA, McGill DB, Fleming JL, Schwartz S, Wieand HS, Rubin J, et al. Patterns of occult bleeding in asymptomatic colorectal cancer. Cancer 1989;63: 1826––30.
- Ton H, Brandsnes, Dale S, Holtlund J, Skuibina E, Schjonsby H, et al. Improved assay for fecal calprotectin. Clinica Chimica Acta 2000;292:41–54.